Title: Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing
endoscopic inflammatory bowel disease severity
Version: 4 Date: 25 Oct 2023
Reviewer:  Cher Shiong Chuah
Reviewer's report:
Thank you for clarifying on the lack of faecal calprotectin data.  The data would suggest a
limited role for platelet albumin ratio in the setting of the unavailability of calprotectin however
the strength of performance of this biomarker is limited. I hope the authors will consider the
introduction of calprotectin testing into their service which although more expensive remains
generally cheaper than colonoscopy.
Title: Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing
endoscopic inflammatory bowel disease severity
Version: 4 Date: 25 Oct 2023
Reviewer:  Cher Shiong Chuah
Reviewer's report:
Thank you for clarifying on the lack of faecal calprotectin data.  The data would suggest a
limited role for platelet albumin ratio in the setting of the unavailability of calprotectin however
the strength of performance of this biomarker is limited. I hope the authors will consider the
introduction of calprotectin testing into their service which although more expensive remains
generally cheaper than colonoscopy.
Please review this paper.
user
Title: Platelet/Albumin ratio and plateletcrit levels are potential new biomarkers for assessing
endoscopic inflammatory bowel disease severity
Version: 4 Date: 25 Oct 2023
Reviewer:  Cher Shiong Chuah
Reviewer's report:
Thank you for clarifying on the lack of faecal calprotectin data.  The data would suggest a
limited role for platelet albumin ratio in the setting of the unavailability of calprotectin however
the strength of performance of this biomarker is limited. I hope the authors will consider the
introduction of calprotectin testing into their service which although more expensive remains
generally cheaper than colonoscopy.
assistant